by Jordana Choucair | Sep 22, 2021 | Life Sciences
The Biden administration is buying 187 million rapid COVID-19 tests from Abbott Laboratories and Celltrion Inc. for $1.2 billion. According to an HHS official, the deals also include options for the federal government to buy more tests. Demand for rapid tests has...
by Jordana Choucair | Sep 21, 2021 | Life Sciences
Johnson & Johnson said a second dose of its COVID-19 vaccine was 94 percent effective at preventing symptomatic disease when given two months after the first shot in a late-stage trial in the U.S. A second study found the extra dose prompted a 12-fold uptick in...
by Jordana Choucair | Sep 20, 2021 | Life Sciences
Pfizer Inc. and BioNTech SE said a late-stage clinical trial showed that their COVID-19 vaccine was safe and generated strong antibody responses in children 5 to 11 years old. However, the companies don’t yet know how well the shot protects against COVID-19 for...
by Jordana Choucair | Sep 16, 2021 | Life Sciences
Ahead of an advisory meeting tomorrow, FDA scientists released documents expressing doubt about whether COVID-19 booster shots are necessary right now. In their review, agency staff said if Pfizer’s vaccine is “still effective at preventing important...
by Jordana Choucair | Sep 15, 2021 | Life Sciences
The U.S. government plans to more directly control where COVID-19 antibody treatments are sent amid a surge in infections and hospitalizations in states with large pockets of unvaccinated people. The Biden administration bought 1.4 million additional doses of...
by Jordana Choucair | Sep 13, 2021 | Life Sciences
Surgeon General Dr. Vivek Murthy defended the Biden administration’s new COVID-19 vaccination mandates, calling them “an appropriate legal measure” akin to other safety requirements for schools and workplaces. Republican governors and other critics...
Recent Comments